J Korean Radiol Soc.  1990 Aug;26(4):609-617. 10.3348/jkrs.1990.26.4.609.

Intra-carotid urokinase thrombolytic therapy in acute cerebral infarction: a preliminary study

Abstract

We conducted a pilot study to evaluate the possibility that the intraarterial thrombolytic therapy might leadto recanalization of the acutely occluded cerebal arteries and subsequent clinical improvement in patients withacute cerebral infarction. Mean time from the onset of symptoms to the start of treatment and mean dosage ofthrombolytic agent, Urokinase, were 6.4 hours and 1,260,000 units, respectively. Seven of 12 cases(58%) with acutecerebral infarction demonstrated successful recanalization. Neurological evaluation at one week and three monthsafter the onset of symptoms suggested better outcome in the cases with recanalization. Repeat CT scan at 24 hoursand one week after the procedure demonstreated the evidence of hemorrhagic infaction in the infarcted territoriesin five cases (41%), but clinical deteriorations were observed in only 2 cases. Though statistical analysis couldnot be done because the limited number of cases, these results suggest that the intra-arterial thrombolytictherapy had a role in the management of acute cerebral infarction.


MeSH Terms

Arteries
Cerebral Infarction*
Humans
Infarction
Pilot Projects
Thrombolytic Therapy*
Tomography, X-Ray Computed
Urokinase-Type Plasminogen Activator*
Urokinase-Type Plasminogen Activator
Full Text Links
  • JKRS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr